Astrid De Cuyper

Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.

Marc Van den Eynde, Nicolas D. Huyghe, Astrid De Cuyper et al. · Journal of Clinical Oncology · 2021 · 29 citations · Full text

Avetuxiri Trial, Immunology, Immunoediting +19

Regorafenib induced severe toxic hepatitis: characterization and discussion

Anne Sacré, Nicolas Lanthier, Hélène Dano et al. · Liver International · 2016 · 26 citations · Full text

397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer

Javier Carrasco, D Schröder, Isabelle Sinapi et al. · Annals of Oncology · 2021 · 26 citations · Full text

Medicine, R-immune Interim Analysis, Immunology +8

Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases

Alice Boilève, Astrid De Cuyper, Alicia Larive et al. · European Journal of Cancer · 2020 · 22 citations · Full text

Systemic Chemotherapy, Hepatology, Health Sciences +13

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

Cédric van Marcke, Natasha Honoré, A. van der Elst et al. · BMC Cancer · 2021 · 10 citations · Full text